EBAG9/RCAS1 Antibody (01) [DyLight 350]

• Reactivity: Hu
• Applications: ELISA
• Clone: 01
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: DyLight 350

EBAG9/RCAS1 Antibody (01) [DyLight 350] Summary

• Immunogen: This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human EBAG9/RCAS1 (Uniprot#: O00559; Arg28-Ser213).
• Isotype: IgG1
• Clonality: Monoclonal
• Host: Mouse
• Gene: EBAG9
• Purity: Protein A purified

Applications/Dilutions

• Dilutions:
  • ELISA
• Application Notes: Optimal dilution of this antibody should be experimentally determined.

Packaging, Storage & Formulations

• Storage: Store at 4C in the dark.
• Buffer: 50mM Sodium Borate
• Preservative: 0.05% Sodium Azide
• Purity: Protein A purified

Notes

DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.

Alternate Names for EBAG9/RCAS1 Antibody (01) [DyLight 350]

• Cancer-associated surface antigen RCAS1
• EB9cancer associated surface antigen
• estrogen receptor binding site associated, antigen, 9
• Estrogen receptor-binding fragment-associated gene 9 protein
• RCAS1PDAF
• receptor-binding cancer antigen expressed on SiSo cells

Background

EBAG9 was identified as an estrogen-responsive gene. Regulation of transcription by estrogen is mediated by estrogen receptor which binds to the estrogen-responsive element (ERE) found in the 5'-flanking region of this gene. The encoded protein is a tumor-associated antigen that is expressed at high frequency in a variety of cancers. Two transcript variants differing in the 5' UTR, but encoding the same protein, have been identified for this gene.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Bioinformatics

• Gene Symbol: EBAG9